Cargando…
Targeted therapies in rheumatoid arthritis: Focus on rituximab
B-cell depletion is a new strategy for treating patients with rheumatoid arthritis (RA). In the past years, several studies have proven the efficacy of anti-CD20 mediated B-cell depletion with rituximab (Mabthera(®)) in RA patients who failed TNF-blocking therapy. The important role of B-cells in th...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721296/ https://www.ncbi.nlm.nih.gov/pubmed/19707303 |